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Physical inactivity significantly contributes to both morbidity 
and mortality, with public health organizations now 
increasingly promoting habitual exercise to reduce the 
negative impact of a sedentary lifestyle.[1,2] Improvements 
in cardiorespiratory fitness are a key target for intervention, 
with maximal oxygen uptake (VO2max) recorded during an 
incremental exercise test to exhaustion, being considered 
the gold standard.[3,4] Cardiorespiratory fitness is inversely 
related to fat mass,[3] type 2 diabetes prevalence,[5] and a more 
reliable predictor of mortality than other established markers, 
such as blood pressure or circulating cholesterol.[6] However, 
the time commitment and cost of performing these tests often 
make them impractical, and chronic illness or frailty in elderly 
patients precludes their application. Consequently, there is 
a need for accurate and reproducible biomarkers for use as 
surrogates of cardiorespiratory fitness.
Morphometric analysis of core muscle cross‑sectional area (CSA) 
is emerging as a strong indicator of health outcomes,[7] with an 
increase in muscle fiber CSA as the main functional adaptation 
arising from aerobic and strength training.[8] The psoas major 
is a large muscle of the abdomen, forming part of the core 
muscle group, assisting lateral rotation and abduction of the hip 
joint.[9] Psoas major CSA has been used in a number of studies 
to predict the total body lean muscle mass,[10] sarcopenia,[11] and 
surgical outcomes in elderly patients.[12,13] It therefore represents 
a potential marker for cardiorespiratory fitness.
In the present study, we would like to characterize how the 
CSA of psoas major and the rectus abdominus (RA), another 
Background and Aim: Cardiorespiratory fitness is an important marker for overall health that significantly correlates with 
obesity‑associated morbidities and mortality. Maximal oxygen uptake (VO2max) recorded during an incremental exercise test is the gold 
standard assessment for aerobic fitness. However, its cost, chronic illness, and frailty often preclude its application. The cross‑sectional 
area (CSA) of the abdominal psoas major muscle is a predictor of sarcopenia and surgery outcomes and represents a promising biomarker 
for cardiorespiratory health. Therefore, in the present study, we have planned to assess the relationship between psoas major CSA, 
anthropometry, and body composition in a UK‑based cohort of 210 men and women. Methods: Body mass (kg), height (cm), waist 
circumference (cm), VO2max, and blood pressure were measured in each participant. The CSA of psoas major, rectus abdominus, and 
another abdominal muscle of the core muscle group were assessed. Results: Following adjustment for height, psoas major CSA was 
found to be a significant predictor of percentage body fat (P = 0.02) in men, and body mass index (BMI) in both men (P = 0.015) and 
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abdominal muscle of the core muscle group, vary with age, 
gender, and BMI in a cross‑sectional population. Second, in a 
subset of our cohort, we have assessed the relationship between 
these muscles CSA and VO2max to gauge their potential as a 
surrogate marker for overall physical health.
MaterIals and Methods
Ethical approval
Written informed consent was acquired from all volunteers. Ethical 
approval for this study was obtained from the Brent National 
Research Ethics Committee (Rec: 12/LO/0139). All studies were 
carried out in accordance with the Declaration of Helsinki. In 
total, 210 participants were recruited through advertisements in 
newspapers, websites, academic newsletters, and inviting male and 
female volunteers of Caucasian ethnicity from the general public. 
Participants presented with no history of chronic disease or excess 
alcohol intake were included in the study. Individuals on prescribed 
medication and pregnant women were excluded from the study.
Anthropometry, blood pressure, and clinical biochemistry
Body mass (kg), height (cm), and waist circumference (cm) 
were measured in each participant by a single experienced 
observer. Fasting glucose, total cholesterol, triglycerides, 
high‑density lipoprotein, low‑density lipoprotein, and insulin 
were measured by standard methods by the Department of 
Chemical Pathology, Imperial College Healthcare National 
Health Service Trust. Blood pressure of the participants 
was measured by trained clinician using an automatic 
sphygmomanometer after 5 min of rest in supine position.
Scanning
Individuals underwent magnetic resonance imaging (MRI) at 
1.5T (Archiva, Philips Medical Systems, The Netherlands) 
following an overnight fast. Participants were in prone position, 
and T1‑weighted axial images of the whole body were obtained 
as described previously.[14] During the same scanning session, 
1H MR spectra were also acquired at 1.5T. Using a surface 
coil, intrahepatocellular lipid (IHCL) was measured relative 
to liver water content.[15]
Psoas major and rectus abdominus
Using the open source image processing program Image‑J (NIH, 
USA), the CSA of the psoas major was manually isolated at 
lumbar point L3/L4. The CSA of the rectus abdominis (RA), 
which can also be clearly observed within the same axial 
slice, was measured from the same MRI images to provide 
a comparison core muscle. The CSA values for each muscle 
group in this study correspond to the sum of the CSA of the 
right‑ and left‑hand sides [Supplementary Figure 1]. Due to 
the strong correlation between psoas major muscle and height, 
values are also presented as CSA/height2 (mm2/m2).[16]
Reproducibility
To test the reproducibility of the manual analysis of psoas major 
and RA CSA, two separate exercises were undertaken. In test 
1, left and right muscle CSA [Supplementary Figure 1] were 
assessed three times in a row by the same observer; psoas: 
(Average [standard deviation [SD]) 4165.1 ± 24.37 mm2, 
coefficient of variation (CoV): 0.59%; RA: 1826.0 ± 9.2 mm2, 
and CoV: 0.50%. In test 2, the same axial slice was measured 
on three separate occasions, at 1 week intervals; average (SD): 
4117.3 ± 61.92 mm2 and CoV: 1.5%. In test 2, the analysis was 
repeated three times on a single, randomly chosen image, 1 week 
apart by the same observer; psoas CoV: 2.9% and RA: 3.7%.
VO2max assessment
An incremental cycling test to exhaustion[4] was carried out 
on the same study day as the MRI scan to obtain VO2max in 
a subset of the cohort (99 individuals [67 male, 32 female]).
Statistical analysis
Student’s t‑test and Spearman’s rank correlations were 
performed on variables; psoas major CSA, RA CSA, and 
VO2max. Linear regression was performed in GraphPad Prism 
version 6.0 (GraphPad Software, USA). IHCL values were 
log transformed after adding + 1 to their values due to the 
nonnormally distributed nature of the outcome.[14] Correlation 
was performed in SPSS 23 (IBM SPSS Statistics for Windows, 
USA) and linear regression in GraphPad Prism. P < 0.05 was 
considered significant. All data were presented as mean ± SD.
results
A total of 210 participants (97F, 113M) took part in the initial 
study to characterize psoas major and RA muscles, both raw 
Table 1: Characteristics of baseline cohort n = 210  
(113 male, 97 female)
Mean±SD Range
Age (year) 43.8±14.5 18‑67
Weight (kg) 79.8±18.1 40.7‑146.6
Height (m) 1.7±0.1 1.5‑2.0
BMI (kg/h2) 26.6±5.1 15.5‑47.5
Waist (cm) 90.2±15.7 56.5‑131
Hip (cm) 103.6±9.5 76‑136
WHR 0.87±0.1 0.67‑1.09
Psoas major CSA (mm2/m2) 2857±1051 718‑7458
Psoas major CSA/height2 942±293 231‑2312





Total fat (kg) 24.3±11.1 5.4‑67.0
Subcutaneous (kg) 19.3±9.2 3.79‑57.3




Subcutaneous peripheral (kg) 13.8±6.1 3.14‑39.7
Visceral (kg) 2.7±1.9 0.31‑10.4
Nonvisceral internal (kg) 2.3±1.0 0.53‑6.2
Data presented as mean±SD. WHR: Waist to hip ratio, BMI: Body mass 
index, CSA: Cross‑sectional area, RA: Rectus abdominis, S‑IMCL: Soleus 
intramyocellular lipid, T‑IMCL: Tibialis intramyocellular lipid, IHCL: 
Intrahepatocellular lipid, SD: Standard deviation
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and adjusted for height, are summarized in Table 1. Average 
psoas CSA/height2 and RA CSA/height2 measurements for 
the entire cohort were 942 + 93 and 436 ± 141, respectively. 
Women presented with significantly smaller psoas and RA when 
compared to men (psoas CSA/height2: female 741 + 167 mm2/m2, 
male 1114 + 266 mm2/h2, P < 0.001; RA CSA/height2: female 
324 ± 73 mm2/h2, male 491 ± 134 mm2/h2, P < 0.001).
Figure 1 shows how muscle CSA, adjusted for height, varied by 
gender, age, BMI, and percentage body fat. Linear regression 
analysis revealed a significant inverse relationship between 
psoas CSA/height2 and age in men [r = 0.13; P = 0.016, 
Figure 1a] with no effect in women [Figure 1b]. Both psoas 
major CSA/height2 (r = 0.28; P = 0.004) and RA CSA/height2 
(r = 0.46; P < 0.001) were significant predictors of BMI in 
women [Figure 1d], while only psoas major CSA/height2 
predicted BMI in men (r = 0.22, P = 0.015). Lastly, psoas 
major CSA/height2 was a significant inverse predictor of 
body fat percentage in men [r = 0.22; P = 0.02, Figure 1e]. 
Examination of the relationship between psoas and RA with 
metabolically adverse fat depots, visceral fat and IHCL, can be 
found in Figure 2. Psoas major CSA/height2 inversely predicted 
visceral fat in men [r = 0.20; P = 0.02, Figure 2a], while RA 
CSA/height2 was a significant predictor of IHCL in women 
[r = 0.22; P = 0.02, Figure 2b].
A comparison of how psoas major and RA muscles (after 
adjustment for height) correlate with study outcomes is shown 
in Supplementary Figure 2. Both psoas major CSA/height2 
and RA/height2 were inversely correlated with age (r = −0.49, 
P < 0.01, r = −0.50, P < 0.01). RA/height2 was significantly 
associated with visceral (r = 0.28, P < 0.01) and nonvisceral 
adipose tissue (r = 0.20, P < 0.05) with no correlation observed 
with psoas major CSA/height2 (P = NS).
Figure 1: Gender‑specific distribution of psoas and rectus abdominus muscle cross‑sectional area/height2 with age, body mass index, and percentage 
body fat. Cross‑sectional area adjusted for height (cross‑sectional area/height2) of psoas major (white square/circle) and rectus abdominus (black 
square/circle) muscles in men (a, c and e) and women (b, d, and f) by age (a and b), body mass index (c and d), and percentage body fat (e and f). 
Linear regression performed in GraphPad Prism with corresponding r2 and P values. □: Male psoas; Δ: Female psoas; ■: Male rectus abdominus; 
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Further investigation in a smaller, older subset of the 
cohort for which VO2max was available (n = 105 (72M), 
age 54.5 ± 8.5 years) was carried out to assess the validity 
of psoas major and RA muscle CSA as a marker for 
cardiorespiratory fitness. Baseline characteristics for this 
cohort are shown in Supplementary Figure 3. Average 
VO2max was 2523 ± 1091 ml/min, with female VO2max lower 
(1520 ± 332 ml/min) than male (3002 ± 998 ml/min). After 
correction for weight, male VO2max was 32.2 ± 12.1 ml/kg/min, 
while female was 19.9 ± 4.3 ml/kg/min.
Correlation analysis between VO2max (adjusted for weight) 
and study outcomes is shown in Table 2. Psoas major 
muscle CSA/height2 (mm2/m2) correlated strongly with 
VO2max (ml/kg/min) (r = 0.56, P < 0.01), with no association 
observed with RA CSA/height2 (r = 0.17, P = NS). Both age 
(r=‑0.64) and height (r = 0.49) correlated strongly with VO2max 
to a similar degree of significance (P < 0.01). Gender‑specific 
analysis revealed a significant correlation between psoas major 
CSA/height2 and VO2max (ml/kg/min) (r = 0.33, P < 0.01) in 
males. In female volunteers, VO2max (ml/kg/min) correlated 
strongly with individual adipose compartments but no 
associations were observed with anthropometric or core muscle 
group measurements [Table 2].
Gender‑specific distribution of psoas major and RA 
CSA/height2 with VO2max (ml/kg/min) is shown in Figure 3. 
Linear regression revealed psoas major CSA/height2 which were 
significant predictors of VO2max in male participants [P < 0.001, 
Figure 3a], with no effect in women [Figure 3b]. RA muscle 
was not found to be a significant predictor of VO2max in either 
men or women [Figure 3].
dIscussIon
In the present study, we characterize how the CSA of psoas 
major and RA muscles varies with age, gender, and BMI in 
a cross‑sectional population. The CSA of the psoas major 
strongly correlated with and was a significant predictor of 
VO2max in a male subset of our cohort, with no such relationship 
observed with RA.
Physical inactivity is a leading cause of most chronic illness 
and practical methods to determine fitness levels are needed 
to enable effective assessment of lifestyle interventions and 
public health planning.[17,18] The use of MRI and computerized 
tomography (CT) scans to measure the content and distribution 
of body fat is increasingly common in both research and 
clinical fields, with cross‑sectional abdominal imaging a 
common procedure in a diagnostic setting. Postprocessing of 
abdominal region scans enables an in‑depth investigation of 
tissue morphology, including the CSA of different muscles.
Muscle size represents a quantitative index, reflecting general 
health and intervention risk.[19] While obtaining whole‑body 
images can be time‑consuming and expensive, studies have 
shown that the CSA of abdominal skeletal muscle provides 
a reliable surrogate of whole body muscle mass.[10] Within 
this region lies the psoas major muscle, a component of the 
core muscle group and a surrogate marker for sarcopenia and 
surgical outcomes.[9,12,20] The RA muscle, often referred to as 
the abdominals, is another component of the core muscle group 
that lies within the L4 region and was included in our analysis 
as a comparator. The psoas major is easily identified on axial 
images in both MRI and CT scan, and analysis of muscle 
CSA can be easily translated into any research institute where 
cross‑sectional imaging of the abdominal region is available 
using this simple and straightforward method.
Our data indicate psoas major CSA predicts VO2max, 
albeit in men only, with no such effect observed with RA. 
Correlation analyses of RA and psoas major CSA adjusted 
for height revealed comparable degrees of association for the 
majority of study outcomes. There was however a significant 
inverse correlation between psoas major CSA and age, a 
Figure 3: Gender‑specific distribution of psoas major and rectus 
abdominus muscle cross‑sectional area/height2 with maximal 
oxygen uptake (ml/kg/min). Cross‑sectional area adjusted for height 
(cross‑sectional area/height2) of psoas major (white square/circle) 
and rectus abdominus (black square/circle) muscles in (a) men and 
(b) women. Linear regression performed in GraphPad Prism with 
corresponding r2 and P values. □: Male psoas; Δ: Female psoas; ■: Male 
rectus abdominus; ▲: Female rectus abdominus
a bFigure 2: Gender‑specific distribution of psoas major and rectus 
abdominus muscle cross‑sectional area/height2 with visceral fat 
and intrahepatocellular lipid. Cross‑sectional area adjusted for 
height (cross‑sectional area/height2) of psoas major (white square/circle) 
and rectus abdominus (black square/circle) muscles in men (a and c) and 
women (b and d) by visceral fat (kg) (a and b) and log intrahepatocellular 
lipid (c and d). Linear regression performed in GraphPad Prism with 
corresponding r2 and P values. □: Male psoas; Δ: Female psoas; ■: Male 
rectus abdominus; ▲: Female rectus abdominus
a b
c d
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relationship not observed with RA. In addition, while the 
psoas was negatively correlated with total, subcutaneous, 
and subcutaneous abdominal fat, RA also showed a positive 
correlation with metabolically adverse visceral and internal fat 
stores.[21] Cardiorespiratory fitness is known to be a significant 
predictor of fat mass and together these data indicate that of the 
two core muscles, the psoas major is the more viable marker 
for metabolic and cardiovascular health.
Ethnic differences exist regarding muscle mass distribution[22] 
and to avoid these potentially confounding effects, study 
recruitment was limited to Caucasians. Further research is 
therefore warranted to determine the influence of broader 
participant demographics on the positive associations between 
psoas major CSA, cardiorespiratory fitness, adiposity, and 
fat‑free mass. As expected, the CSA of both psoas major and 
RA muscles was significantly smaller in women compared 
to men, necessitating gender‑specific analysis. The inverse 
relationship observed between psoas and age in men was 
expected and reflects an established association.[22] However, 
in women, we failed to see a reduction in either psoas major 
or RA size as age increased, or indeed any correlation 
between VO2max and other outcomes. Indeed, it is clear that 
the significant associations we did observe between VO2max 
and study outcomes were driven by the relationship in men.
Several factors may have contributed to this; first, the number of 
women for which VO2max data were available was considerably 
smaller (n = 33) compared to men (n = 72). Second, the range of 
VO2max values was more limited in women (511–1175 ml/min) 
than men (663–2312 ml/min), perhaps reflecting the reduced 
levels of reported physical activity in women who participated; 
24% reported “fit” (corresponding to >5 h exercise per week), 
compared to 42% of the men. Interventional studies which 
employ exercise and subsequently measure the effects on 
VO2max and core muscle size will be required to eliminate the 
confounding effects of age and determine the efficacy of psoas 
as a marker of metabolic fitness.
Limitations of the study
Sample size in the present study was less.
conclusIon
Our findings indicate that psoas major CSA measured at L4 is 
strongly associated with cardiorespiratory fitness, adiposity, 
and fat‑free mass. Hence, psoas major is a potential marker of 
cardiorespiratory fitness. Additional work in a larger, racially 
diverse population with a more expansive range of fitness 
levels will be required to confirm its utility.
Financial support and sponsorship
GF, JB, and ELT were all funded through the Nutritech study 
(FP7‑KBBE‑289511).
Conflicts of interest
There are no conflicts of interest.
references
1. World Health Organisation. Global Strategy on Diet, Physical Activity 
and Health: Physical Activity and Adults. World Health Organisation; 
2015. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA57/
A57_9‑en.pdf?ua=1.
2. Physical Activity Guidelines for Adults – Live Well – NHS Choices. 
Department of Health, NHS; 2013.
3. Dunn AL, Marcus BH, Kampert JB, Garcia ME, Kohl HW, Blair SN. 
Comparison of lifestyle and structured interventions to increase physical 
activity and cardiorespiratory fitness: A randomized trial. JAMA 
1999;281:327‑34.
4. Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G. 
Variability of aerobic performance in the laboratory and its physiologic 
correlates. Int J Sports Med 1985;6:197‑201.
5. Wei M, Gibbons LW, Mitchell TL, Kampert JB, Lee CD, Blair SN. The 
association between cardiorespiratory fitness and impaired fasting glucose 
and type 2 diabetes mellitus in men. Ann Intern Med 1999;130:89‑96.
6. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. 
Exercise capacity and mortality among men referred for exercise testing. 
N Engl J Med 2002;346:793‑801.
Table 2: Correlation analysis of maximal oxygen uptake 
with study outcomes
VO2max (ml/kg/min) All Male Female
Age (year) −0.64** −0.61** −0.08
Weight (kg) 0.02 −0.32** −0.30
Height (m) 0.49** 0.21 −0.11
BMI (kg/h2) −0.35** −0.47** −0.33
Waist (cm) −0.19 −0.62** −0.01
Hip (cm) −0.19 −0.43** −0.05
WHR −0.10 −0.65** 0.10
Psoas major CSA/height2 0.56** 0.33** 0.06
RA/height2 0.17 −0.15 0.22
SBP −0.10 −0.15 −0.23
DBP −0.11 −0.30 −0.20
Glucose (mmol./l) −0.06 −0.14 0.06
Insulin (mU/l) 0.04 −0.02 −0.06
Cholesterol (mmol/l) 0.10 0.35* 0.04
Triglycerides (mmol/l) 0.17 0.08 −0.04
HDL cholesterol (mmol/l) −0.10 0.21 0.19
LDL cholesterol (mmol/l) −0.03 0.12 −0.02
Cholesterol: LDL ratio 0.13 0.03 −0.18
S‑IMCL −0.15 −0.19 −0.38*
T‑IMCL −0.15 −0.17 0.03
IHCL −0.15 −0.24 −0.14
Total fat (kg) −0.63** −0.58** −0.41*
Subcutaneous (kg) −0.60** −0.49** −0.43*
Internal (kg) −0.49** −0.71** −0.26
Subcutaneous abdominal (kg) −0.55** −0.45** −0.42*
Subcutaneous peripheral (kg) −0.62** −0.49** −0.42*
Visceral (kg) −0.39** −0.66** −0.26
Nonvisceral internal (kg) −0.57** −0.71** −0.21
Correlation analysis of VO2max (ml/kg/min) with anthropometric, metabolic, 
and body composition outcomes. Data shown are Pearson’s coefficients; 
shaded boxes indicate a significant correlation, bold typeface indicates 
a higher degree of significance. *P<0.05, **P<0.01. SBP: Systolic 
blood pressure, DBP: Diastolic blood pressure, WHR: Waist to hip 
ratio, BMI: Body mass index, CSA: Cross‑sectional area, RA: Rectus 
abdominis, LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, 
S‑IMCL: Soleus intramyocellular lipid, T‑IMCL: Tibialis intramyocellular 
lipid, IHCL: Intrahepatocellular lipid, VO2max: Maximal oxygen uptake
Fitzpatrick, et al.: Psoas major muscle as a marker of cardiorespiratory fitness
International Journal of Clinical and Experimental Physiology ¦ Volume 4 ¦ Issue 1 ¦ January‑March 201720
7. Englesbe MJ, Lee JS, He K, Fan L, Schaubel DE, Sheetz KH, et al. 
Analytic morphomics, core muscle size, and surgical outcomes. Ann 
Surg 2012;256:255‑61.
8. Bogdanis GC. Effects of physical activity and inactivity on muscle 
fatigue. Front Physiol 2012;3:142.
9. Regev GJ, Kim CW, Tomiya A, Lee YP, Ghofrani H, Garfin SR, et al. 
Psoas muscle architectural design, in vivo sarcomere length range, and 
passive tensile properties support its role as a lumbar spine stabilizer. 
Spine (Phila Pa 1976) 2011;36:E1666‑74.
10. Shen W, Punyanitya M, Wang Z, Gallagher D, St‑Onge MP, Albu J, 
et al. Total body skeletal muscle and adipose tissue volumes: Estimation 
from a single abdominal cross‑sectional image. J Appl Physiol 
2004;97:2333‑8.
11. Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas 
cross‑sectional area measurement is a quick and easy method to assess 
sarcopenia and predicts major surgical complications. Colorectal Dis 
2015;17:O20‑6.
12. Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, et al. 
Prognostic value of muscle atrophy in cirrhosis using psoas muscle 
thickness on computed tomography. J Hepatol 2014;60:1151‑7.
13. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, 
et al. Sarcopenia and mortality after liver transplantation. J Am Coll 
Surg 2010;211:271‑8.
14. Thomas EL, Parkinson JR, Frost GS, Goldstone AP, Doré CJ, 
McCarthy JP, et al. The missing risk: MRI and MRS phenotyping 
of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 
2012;20:76‑87.
15. Thomas EL, Hamilton G, Patel N, O’Dwyer R, Dore CJ, Goldin RD, 
et al. Hepatic triglyceride content and its relation to body adiposity: 
A magnetic resonance imaging and proton magnetic resonance 
spectroscopy study. Gut 2005;54:122‑7.
16. Bhamidipati PK, Carson KR, Wildes TM. Psoas cross‑sectional area as 
radiographic measure of sarcopenia does not predict overall survival in 
multiple myeloma. Blood 2013;122:5236.
17. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of 
chronic diseases. Compr Physiol 2012;2:1143‑211.
18. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. 
Effect of physical inactivity on major non‑communicable diseases 
worldwide: An analysis of burden of disease and life expectancy. Lancet 
2012;380:219‑29.
19. Lee JS, He K, Harbaugh CM, Schaubel DE, Sonnenday CJ, Wang SC, 
et al. Frailty, core muscle size, and mortality in patients undergoing 
open abdominal aortic aneurysm repair. J Vasc Surg 2011;53:912‑7.
20. Sheetz KH, Zhao L, Holcombe SA, Wang SC, Reddy RM, Lin J, et al. 
Decreased core muscle size is associated with worse patient survival 
following esophagectomy for cancer. Dis Esophagus 2013;26:716‑22.
21. Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M, et al. 
Why visceral fat is bad: Mechanisms of the metabolic syndrome. 
Obesity (Silver Spring) 2006;14 Suppl 1:16S‑9S.
22. Silva AM, Shen W, Heo M, Gallagher D, Wang Z, Sardinha LB, et al. 
Ethnicity‑related skeletal muscle differences across the lifespan. Am J 
Hum Biol 2010;22:76‑82.
Supplementary Figure 3: Baseline characteristics of 
cardiorespiratory assessment cohort (n=102)
n=105 (72 male) Range
Age (year) 54.5±8.5 35‑66
Weight (kg) 88.2±16.8 58.6‑146.6
Height (m) 1.74±0.1 1.51‑1.95
BMI (kg/m2) 29.1±4.0 19.4‑42.4
Waist (cm) 99.5±12.7 71.6‑131.0
Hip (cm) 107.9±8.4 88.5‑136.0
WHR 0.92±0.08 0.67‑1.09
Psoas CSA (mm2) 3010±1115 1165.9‑7458
Psoas CSA/height (m)2 977±301 511‑2312
RA CSA (mm2) 1333±515 554‑3217
RA/height (m)2 436±141 198‑997
VO2max (ml/min) 2523±1091 930‑5402
VO2max (ml/kg/min) 28.2±11.8 0‑67
SBP (mmHg) 127±12 97‑157
DBP (mmHg) 771±9.0 52‑96
Glucose (mmol/l) 5.06±0.55 4.1‑7.0
Insulin (mU/l) 11.46±8.17 1.73‑57.1
Cholesterol (mmol/l) 5.54±0.84 3.4‑7.9
Triglycerides (mmol/l) 1.92±1.39 0.37‑9.37
HDL cholesterol (mmol/l) 1.37±0.36 0.62‑2.28
LDL cholesterol (mmol/l) 3.35±0.77 1.65‑5.4




Total fat (kg) 28.5±10.6 9.1‑61.2
Subcutaneous (kg) 22.0±9.1 7.1‑52.4
Internal (kg) 6.5±2.7 1.3‑14.7
Subcutaneous abdominal (kg) 6.5±3.2 1.5‑18.17
Subcutaneous peripheral (kg) 15.5±6.0 5.6‑35.7
Visceral (kg) 3.8±1.9 0.39‑10.4
Nonvisceral internal (kg) 2.8±0.97 0.87‑6.2
Data presented as mean±SD. SD: Standard deviation, SBP: Systolic 
blood pressure, DBP: Diastolic blood pressure, WHR: Waist to hip ratio, 
BMI: Body mass index, CSA: Cross‑sectional area, RA: Rectus abdominis, 
LDL: Low‑density lipoprotein, HDL: High‑density lipoprotein, S‑IMCL: 
Soleus intramyocellular lipid, T‑IMCL: Tibialis intramyocellular lipid, 
IHCL: Intrahepatocellular lipid, VO2max: Maximal oxygen uptake
Supplementary Figure 2: Correlation analysis of psoas 
major and rectus abdominis muscle cross‑sectional area 
adjusted for height
Psoas/height2 RA/height2
Age (year) −0.49** −0.50**
Weight (kg) 0.48** 0.56**
Height (m) 0.51** 0.48**
BMI (kg/h2) 0.25** 0.40**
Waist (cm) 0.24* 0.39**




Glucose (mmol/l) 0.13 0.11
Insulin (mU/l) 0.13 0.03
Cholesterol (mmol/l) −0.49** −0.38**
Triglycerides (mmol/l) −0.21 −0.35**
HDL cholesterol (mmol/l) 0.30* 0.17
LDL cholesterol (mmol/l) 0.02 0.07




Total fat (kg) −0.23* −0.06
Subcutaneous (kg) −0.33** −0.20*
Internal (kg) 0.01 0.18
Subcutaneous abdominal (kg) −0.22* −0.06
Subcutaneous peripheral (kg) −0.17 0.03
Visceral (kg) 0.14 0.28**
Nonvisceral internal (kg) 0.17 0.20*
Data shown are Pearson’s coefficients; shaded boxes indicate a 
significant correlation. *P<0.05, **P<0.01. SBP: Systolic blood pressure, 
DBP: Diastolic blood pressure, WHR: Waist to hip ratio, BMI: Body 
mass index, RA: Rectus abdominis, LDL: Low‑density lipoprotein, HDL: 
High‑density lipoprotein, S‑IMCL: Soleus intramyocellular lipid, T‑IMCL: 
Tibialis intramyocellular lipid, IHCL: Intrahepatocellular lipid
Supplementary Figure 1: Psoas and rectus abdominus coronal slices at 
position L4 used to identification and manually measure cross‑sectional 
area of psoas major (a and b) and rectus abdominis (c and d) muscles 
using Image –J software
a b
c d
